Trial intelligence / Profile preview

Inhaled Iloprost for Disproportionate PH in COPD

NCT01116063Phase 4Unknown

Sponsor
Carmel Medical Center
Start
May 2010
Primary completion
Jan 2013
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of iloprost in pulmonary hypertension (PH), sponsored by Carmel Medical Center. Status: unknown.

02

Drugs

iloprost
03

Conditions

pulmonary hypertension (PH)

Beyond the preview

Go deeper on NCT01116063.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01116063.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call